NXEN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seelos Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.025 EUR -90.23% Market Closed

Market Cap: €24.8m

S	Seelos Therapeutics Inc F:NXEN	US
T	Trade Desk Inc F:TT8	US
T	T-Mobile US Inc LSE:0R2L	US
T	Tanzanian Gold Corp F:TRG	CA
	National Grid PLC F:NNGF	UK
F	Fomento de Construcciones y Contratas SA SWB:FCC	ES
C	Carrefour SA OTC:CRERF	FR
B	Barrick Gold Corp NYSE:GOLD	CA
V	Vale Indonesia Tbk PT SWB:XT3B	ID
B	BP PLC XMUN:BPE5	UK
	Place Holdings Ltd F:95N	SG
E	EQT Corp DUS:EQ6	US
O	OWC Pharmaceutical Research Corp OTC:OWCP	IL
C	Clearside Biomedical Inc XBER:CLM	US
I	Insurance Australia Group Ltd OTC:IAUGF	AU

Profitability Summary

Seelos Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 480%

Negative 3Y Average Operating Margin

-2 671%

Operating Margin is Increasing

-4 856% > -1 480%

Exceptional Net Margin

203%

Negative 3Y Average Net Margin

-2 657%

Net Margin is Increasing

-7 097% > 203%

Negative Free Cash Flow Margin

-659%

Negative 3Y Average Free Cash Flow Margin

-1 693%

Free Cash Flow Margin is Increasing

-3 533% > -659%

Negative ROE

-11%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

1 399%

ROIC is Increasing

-1 274% > 426%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.